Skip to content
Our 2022 Year in Review is now live.
  • Insights

      Weekly Bulletin

      Your weekly recap of news and analysis from the psychedelic sector.

      Read the Latest

      Research Review

      A monthly review of the most important psychedelics research.

      Review Archive

      News & Interviews

      The latest news from across the psychedelics space.

      Explore Now
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents
      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents

      Psychedelic Legalization & Decriminalization Tracker

      Mapping psychedelic drug policy reform across the United States

      Explore the Tracker
      New: Oregon Local Jurisdiction Tracker

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Explore the Tracker
  • Companies

      Stocks & Companies Directory

      A directory of all the major psychedelics stocks, companies and ETFs.

      Access Directory

      Sector Landscape Map

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Stock Watchlist

      A one-stop overview of psychedelics stocks financial performance.

      Explore Now
  • Psychedelic Careers
  • Contact
Search
Close
Read more about the article Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

  • Post published:November 19, 2021
  • Post category:Press Release
Read more about the article Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline

Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline

  • Post published:September 14, 2021
  • Post category:Press Release
Read more about the article Wesana Health Announces Closing of PsyTech Acquisition

Wesana Health Announces Closing of PsyTech Acquisition

  • Post published:September 9, 2021
  • Post category:Press Release
Read more about the article Distinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory Board

Distinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory Board

  • Post published:August 31, 2021
  • Post category:Press Release
Read more about the article Wesana Health Highlights Recent Appointments to Board of Directors

Wesana Health Highlights Recent Appointments to Board of Directors

  • Post published:August 19, 2021
  • Post category:Press Release
Read more about the article Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury

Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury

  • Post published:August 11, 2021
  • Post category:Press Release
Read more about the article Ian Burnstein Joins Wesana Health Advisory Board

Ian Burnstein Joins Wesana Health Advisory Board

  • Post published:July 14, 2021
  • Post category:Press Release
Read more about the article Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.

Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.

  • Post published:July 13, 2021
  • Post category:Press Release
Read more about the article Wesana Health Partners with University of South Carolina

Wesana Health Partners with University of South Carolina

  • Post published:June 24, 2021
  • Post category:Press Release
Read more about the article Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

  • Post published:May 27, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

  • Psychedelic Alpha © 2022, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.